In memory
What Gwen Ifill's Story Can Help Us Understand About Uterine (Endometrial) Cancer
The trailblazing journalist died in 2016 of endometrial cancer. Here is what that diagnosis means, explained calmly and simply.
Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.
The news
Gwen Ifill was a widely admired journalist, the longtime moderator of Washington Week and co-anchor of the PBS NewsHour, and a barrier-breaking figure in American broadcast news. She died on November 14, 2016, at age 61. Her family and colleagues said the cause was endometrial cancer, a form of uterine cancer.
That is what was publicly shared. We do not know, and will not speculate about, private details of her diagnosis or care beyond what was made public.
Why people are talking about it
Ifill's death drew new public attention to endometrial cancer, a common cancer that many people know little about. When a respected public figure dies of a disease, it often prompts others to ask what it is and whether it can be found early. That instinct, when it leads to calm and accurate information, is a healthy one.
What this cancer means
According to the National Cancer Institute, uterine cancers fall into two main types: endometrial cancer, which is common, and uterine sarcoma, which is rare. Endometrial cancer begins in the endometrium, the inner lining of the uterus. NCI notes that endometrial cancer can often be cured, while uterine sarcoma is often more aggressive and harder to treat.
Because these are two distinct diagnoses, understanding which one is present matters, and a healthcare team is the right source for what a specific diagnosis means.
What to remember
Every person's situation is different. A public story tells us only what a family chose to share; it cannot tell us how any individual's cancer will behave. News coverage is not a diagnosis or medical advice. What a story like Ifill's can do is prompt awareness, and encourage people to pay attention to their own bodies and to seek care when something changes.
Awareness, screening, and prevention
NCI explains that there is no routine screening test recommended for endometrial cancer in women at average risk; instead, it emphasizes paying attention to symptoms. Abnormal vaginal bleeding, especially bleeding after menopause, is a symptom NCI notes should be discussed with a healthcare professional. On prevention, NCI describes certain hormone-related factors that can affect endometrial cancer risk. If you have questions about your own risk, our free screening check-up tool is a gentle way to think through what conversations may be worth having with your care team.
Turning a story into something useful
Learning the difference between endometrial cancer and uterine sarcoma, knowing that abnormal bleeding is worth raising with a professional, and talking openly with a healthcare team are calm, practical takeaways. Supporting free, trustworthy cancer education helps this kind of information reach more people who need it.
Questions to ask a healthcare team
- Is any bleeding or symptom I've noticed worth investigating further?
- Do my personal or family history affect my risk of uterine cancer?
- What signs should prompt me to come back for a check?
- Where can I find reliable, plain-language information about this cancer?